Top 5 Stocks to Buy Now
→ Why this tiny stock may move before the SpaceX IPO drops (From Behind the Markets) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo Q1 2026 Earnings Report

Terumo logo
$14.00 0.00 (0.00%)
As of 06/18/2026 03:59 PM Eastern
ProfileEarnings HistoryForecast

Terumo EPS Results

Actual EPS
$0.20
Consensus EPS
$0.17
Beat/Miss
Beat by +$0.03
One Year Ago EPS
N/A

Terumo Revenue Results

Actual Revenue
$1.76 billion
Expected Revenue
$1.80 billion
Beat/Miss
Missed by -$32.81 million
YoY Revenue Growth
N/A

Terumo Announcement Details

Quarter
Q1 2026
Date
8/7/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Thursday, August 6, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings Headlines

Terumo Corporation (TRUMY) Analyst/Investor Day Transcript
June 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4914117-terumo-corporation-trumy-analyst-investor-day-transcript
Terumo Corp. (OTCMKTS:TRUMY) Sees Large Growth in Short Interest
June 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30829717
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel
June 21 at 1:00 AM  |  Behind the Markets (Ad)
Terumo ADR Stock Price History
May 17, 2026  |  investing.comhttps://www.investing.com/equities/terumo-adr-historical-data
Terumo Corporation (TRUMY) Q4 2026 Earnings Call Transcript
May 17, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4905155-terumo-corporation-trumy-q4-2026-earnings-call-transcript
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
February 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4870046-terumo-corporation-trumy-q3-2026-earnings-call-transcript
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags. Through its Terumo BCT subsidiary, the company also provides apheresis, blood component management and cell therapy technologies used by blood banks, transfusion services and cell-therapy developers. Terumo’s portfolio emphasizes single-use medical devices and clinically oriented systems designed to improve procedural outcomes and patient safety.

Founded in the early 20th century and headquartered in Tokyo, Terumo has grown into a multinational supplier with operations and sales networks across Asia, the Americas and Europe. The company distributes products globally through a combination of regional subsidiaries, direct sales teams and distribution partners, serving hospitals, specialty clinics and blood centers. As a publicly listed Japanese corporation, Terumo also maintains an American depositary receipt (ADR) listing that enables trading on overseas markets.

View Terumo Profile
Earnings Tools